375 related articles for article (PubMed ID: 9737683)
1. Inhibition of erythroid differentiation and induction of megakaryocytic differentiation by thrombopoietin are regulated by two different mechanisms in TPO-dependent UT-7/c-mpl and TF-1/c-mpl cell lines.
Goncalves F; Lacout C; Féger F; Cohen-Solal K; Guichard J; Cramer E; Vainchenker W; Duménil D
Leukemia; 1998 Sep; 12(9):1355-66. PubMed ID: 9737683
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO.
Komatsu N; Kunitama M; Yamada M; Hagiwara T; Kato T; Miyazaki H; Eguchi M; Yamamoto M; Miura Y
Blood; 1996 Jun; 87(11):4552-60. PubMed ID: 8639823
[TBL] [Abstract][Full Text] [Related]
3. Developmental expression of plasminogen activator inhibitor-1 associated with thrombopoietin-dependent megakaryocytic differentiation.
Madoiwa S; Komatsu N; Mimuro J; Kimura K; Matsuda M; Sakata Y
Blood; 1999 Jul; 94(2):475-82. PubMed ID: 10397715
[TBL] [Abstract][Full Text] [Related]
4. Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin.
Porteu F; Rouyez MC; Cocault L; Bénit L; Charon M; Picard F; Gisselbrecht S; Souyri M; Dusanter-Fourt I
Mol Cell Biol; 1996 May; 16(5):2473-82. PubMed ID: 8628315
[TBL] [Abstract][Full Text] [Related]
5. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C mediates the mitogenic action of thrombopoietin in c-Mpl-expressing UT-7 cells.
Hong Y; Dumènil D; van der Loo B; Goncalves F; Vainchenker W; Erusalimsky JD
Blood; 1998 Feb; 91(3):813-22. PubMed ID: 9446641
[TBL] [Abstract][Full Text] [Related]
7. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
Drexler HG; Quentmeier H
Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
[TBL] [Abstract][Full Text] [Related]
8. Thrombopoietin supports the continuous growth of cytokine-dependent human leukemia cell lines.
Drexler HG; Zaborski M; Quentmeier H
Leukemia; 1997 Apr; 11(4):541-51. PubMed ID: 9096695
[TBL] [Abstract][Full Text] [Related]
9. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation.
Goncalves F; Lacout C; Villeval JL; Wendling F; Vainchenker W; Dumenil D
Blood; 1997 May; 89(10):3544-53. PubMed ID: 9160659
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin activates a STAT5-like factor in hematopoietic cells.
Pallard C; Gouilleux F; Bénit L; Cocault L; Souyri M; Levy D; Groner B; Gisselbrecht S; Dusanter-Fourt I
EMBO J; 1995 Jun; 14(12):2847-56. PubMed ID: 7796811
[TBL] [Abstract][Full Text] [Related]
11. Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines.
Drexler HG; Quentmeier H
Hum Cell; 1996 Dec; 9(4):309-16. PubMed ID: 9183663
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin stimulates VEGF release from c-Mpl-expressing cell lines and haematopoietic progenitors.
Bobik R; Hong Y; Breier G; Martin JF; Erusalimsky JD
FEBS Lett; 1998 Feb; 423(1):10-4. PubMed ID: 9506832
[TBL] [Abstract][Full Text] [Related]
14. Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line.
Matsumura I; Nakajima K; Wakao H; Hattori S; Hashimoto K; Sugahara H; Kato T; Miyazaki H; Hirano T; Kanakura Y
Mol Cell Biol; 1998 Jul; 18(7):4282-90. PubMed ID: 9632812
[TBL] [Abstract][Full Text] [Related]
15. A non-peptide compound which can mimic the effect of thrombopoietin via c-Mpl.
Kimura T; Kaburaki H; Tsujino T; Ikeda Y; Kato H; Watanabe Y
FEBS Lett; 1998 May; 428(3):250-4. PubMed ID: 9654143
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin supports in vitro erythroid differentiation via its specific receptor c-Mpl in a human leukemia cell line.
Yamada M; Komatsu N; Kirito K; Kashii Y; Tomizuka H; Okada K; Endo T; Fukumaki Y; Shinjo K; Abe K; Miura Y
Cell Growth Differ; 1998 Jun; 9(6):487-96. PubMed ID: 9663467
[TBL] [Abstract][Full Text] [Related]
17. In vitro development of erythroid and megakaryocytic cells from a UT-7 subline, UT-7/GM.
Komatsu N; Kirito K; Shimizu R; Kunitama M; Yamada M; Uchida M; Takatoku M; Eguchi M; Miura Y
Blood; 1997 Jun; 89(11):4021-33. PubMed ID: 9166841
[TBL] [Abstract][Full Text] [Related]
18. Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway.
Rouyez MC; Boucheron C; Gisselbrecht S; Dusanter-Fourt I; Porteu F
Mol Cell Biol; 1997 Sep; 17(9):4991-5000. PubMed ID: 9271377
[TBL] [Abstract][Full Text] [Related]
19. A functional role of mitogen-activated protein kinases, erk1 and erk2, in the differentiation of a human leukemia cell line, UT-7/GM: a possible key factor for cell fate determination toward erythroid and megakaryocytic lineages.
Uchida M; Kirito K; Shimizu R; Miura Y; Ozawa K; Komatsu N
Int J Hematol; 2001 Jan; 73(1):78-83. PubMed ID: 11372759
[TBL] [Abstract][Full Text] [Related]
20. Insights into the cellular mechanisms of erythropoietin-thrombopoietin synergy.
Papayannopoulou T; Brice M; Farrer D; Kaushansky K
Exp Hematol; 1996 Apr; 24(5):660-9. PubMed ID: 8605971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]